|
GB8613481D0
(en)
|
1986-06-04 |
1986-07-09 |
Diatech Ltd |
Translation of mrna
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US6867195B1
(en)
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
GB9103974D0
(en)
|
1991-02-26 |
1991-04-10 |
Norsk Hydro As |
Therapeutically useful peptides or peptide fragments
|
|
GB2284210B
(en)
|
1993-11-26 |
1997-11-12 |
British Tech Group |
Translational enhancer DNA from a kinesin gene
|
|
US6027726A
(en)
|
1994-09-30 |
2000-02-22 |
Inex Phamaceuticals Corp. |
Glycosylated protein-liposome conjugates and methods for their preparation
|
|
US5824497A
(en)
|
1995-02-10 |
1998-10-20 |
Mcmaster University |
High efficiency translation of mRNA molecules
|
|
US6503503B1
(en)
|
1997-05-13 |
2003-01-07 |
Duke University |
Allogeneic cellular vaccine
|
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
GB2328689A
(en)
|
1997-08-27 |
1999-03-03 |
Norsk Hydro As |
Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer
|
|
US20060009633A9
(en)
|
1997-11-13 |
2006-01-12 |
Genset, S.A. |
Complementary DNAs encoding proteins with signal peptides
|
|
NO309798B1
(no)
|
1999-04-30 |
2001-04-02 |
Targovax As |
Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
|
|
ES2340499T3
(es)
|
2001-06-05 |
2010-06-04 |
Curevac Gmbh |
Arnm de antigeno tumoral estabilizado con un contenido de g/c aumentado.
|
|
EP2447370B1
(en)
|
2001-09-28 |
2018-07-18 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
AU2002349784A1
(en)
|
2001-12-03 |
2003-06-17 |
Asahi Kasei Pharma Corporation |
Nf-kappab activating genes
|
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
|
GB0221574D0
(en)
|
2002-09-17 |
2002-10-23 |
Isis Innovation |
Treatments
|
|
EP1556082A1
(en)
|
2002-10-22 |
2005-07-27 |
Aventis Pasteur Limited |
Anti-cancer vaccines and high-dose cytokines as adjuvants
|
|
EP2322200A3
(en)
|
2002-10-29 |
2011-07-27 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
KR101455222B1
(ko)
|
2002-12-16 |
2014-10-31 |
글로브이뮨 |
면역 요법으로서의 효모계 백신
|
|
US8343502B2
(en)
|
2002-12-16 |
2013-01-01 |
Globeimmune, Inc. |
Yeast-based vaccines as immunotherapy
|
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
|
PL2578685T3
(pl)
|
2005-08-23 |
2020-01-31 |
The Trustees Of The University Of Pennsylvania |
Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
|
|
US7670840B2
(en)
|
2006-01-05 |
2010-03-02 |
The Ohio State University Research Foundation |
Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors
|
|
EP1969147B1
(en)
|
2006-01-05 |
2014-07-30 |
The Ohio State University Research Foundation |
microRNA-based methods for the diagnosis of stomach cancer
|
|
EP2522746B1
(en)
|
2006-03-02 |
2014-11-12 |
The Ohio State University Research Foundation |
MicroRNA expression profile associated with pancreatic cancer
|
|
BRPI0709340A2
(pt)
*
|
2006-03-27 |
2013-04-16 |
Globeimmune, Inc. |
mutaÇço ras e composiÇÕes e mÉtodos de uso da mesma
|
|
US20090131348A1
(en)
|
2006-09-19 |
2009-05-21 |
Emmanuel Labourier |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
|
US8252538B2
(en)
|
2006-11-01 |
2012-08-28 |
The Ohio State University |
MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
WO2008073915A2
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Micrornas differentially expressed in leukemia and uses thereof
|
|
WO2008147974A1
(en)
|
2007-05-23 |
2008-12-04 |
University Of South Florida |
Micro-rnas modulating immunity and inflammation
|
|
US20090099034A1
(en)
|
2007-06-07 |
2009-04-16 |
Wisconsin Alumni Research Foundation |
Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
|
|
CN101784564B
(zh)
|
2007-07-13 |
2014-07-02 |
约翰霍普金斯大学 |
B7-dc变体
|
|
HRP20150820T1
(xx)
|
2007-07-27 |
2015-09-11 |
Immatics Biotechnologies Gmbh |
Nova imunoterapija protiv neuronskih tumora i tumora mozga
|
|
US8476419B2
(en)
|
2007-09-14 |
2013-07-02 |
Vrije Universiteit Brussel |
Enhancing the T-cells stimulatory capacity of human antigen presenting cells and their use in vaccination
|
|
WO2009046738A1
(en)
*
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
|
CN101918594A
(zh)
|
2007-11-30 |
2010-12-15 |
俄亥俄州立大学研究基金会 |
肺癌中外周血中的微rna表达特征谱和靶向
|
|
WO2009111088A2
(en)
|
2008-01-02 |
2009-09-11 |
The Johns Hopkins University |
Antitumor immunization by liposomal delivery of vaccine to the spleen
|
|
EP2260110B1
(en)
|
2008-02-08 |
2014-11-12 |
Asuragen, INC. |
miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
|
|
CA2717026A1
(en)
|
2008-02-28 |
2009-09-03 |
The Ohio State University Research Foundation |
Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof
|
|
EP2112235A1
(en)
|
2008-04-24 |
2009-10-28 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma
|
|
WO2009149539A1
(en)
|
2008-06-10 |
2009-12-17 |
Université de Montréal |
Enhancing antigen-specific cd8+ t cell response using irf-7 mrna
|
|
JP2011529708A
(ja)
|
2008-08-04 |
2011-12-15 |
ユニバーシティ オブ マイアミ |
自然免疫応答の調節因子ｓｔｉｎｇ（インターフェロン遺伝子の刺激因子）
|
|
WO2010018563A2
(en)
|
2008-08-12 |
2010-02-18 |
Rosetta Genomics Ltd. |
Compositions and methods for the prognosis of lymphoma
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
US9074206B2
(en)
|
2008-11-13 |
2015-07-07 |
Fudan University |
Compositions and methods for micro-RNA expression profiling of colorectal cancer
|
|
EP2358902A1
(en)
|
2008-12-10 |
2011-08-24 |
Universität Regensburg |
Compositions and methods for micro-rna expression profiling of cancer stem cells
|
|
EP2246433A1
(de)
*
|
2009-04-30 |
2010-11-03 |
Mologen AG |
Concatemere zur Immunmodulation
|
|
EP2427574A2
(en)
|
2009-05-08 |
2012-03-14 |
The Ohio State University Research Foundation |
Microrna expression profiling and targeting in chronic obstructive pulmonary disease (copd) lung tissue and methods of use thereof
|
|
KR101766408B1
(ko)
|
2009-06-10 |
2017-08-10 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
WO2011076143A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expression profiling of lung cancer
|
|
WO2011076142A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expession profiling in plasma of colorectal cancer
|
|
EP2341145A1
(en)
|
2009-12-30 |
2011-07-06 |
febit holding GmbH |
miRNA fingerprint in the diagnosis of diseases
|
|
WO2011094683A2
(en)
|
2010-01-29 |
2011-08-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Method of identifying myelodysplastic syndromes
|
|
EP2354246A1
(en)
|
2010-02-05 |
2011-08-10 |
febit holding GmbH |
miRNA in the diagnosis of ovarian cancer
|
|
US20130059015A1
(en)
|
2010-03-11 |
2013-03-07 |
H. Lee Moffitt Cancer Center & Research Institute |
Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
|
|
EP2569633B1
(en)
|
2010-05-14 |
2016-02-10 |
The General Hospital Corporation |
Compositions and methods of identifying tumor specific neoantigens
|
|
WO2011157294A1
(en)
|
2010-06-16 |
2011-12-22 |
Universita' Degli Studi Di Padova |
Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
|
|
LT4226941T
(lt)
*
|
2010-08-31 |
2025-01-10 |
Glaxosmithkline Biologicals Sa |
Pegilintos liposomos, skirtos imunogeną koduojančios rnr pristatymui
|
|
SI4043040T1
(sl)
*
|
2010-08-31 |
2023-04-28 |
Glaxosmithkline Biologicals Sa |
Mali liposomi za dostavo imunogen-kodirajoče RNA
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
SI2633034T1
(en)
|
2010-10-26 |
2018-05-31 |
Friedrich-Alexander-Universitaet Erlangen-Nuernberg |
Dendritic cells with manipulated signal path NFkB
|
|
CA2824526C
(en)
|
2011-01-11 |
2020-07-07 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
|
WO2012151212A1
(en)
|
2011-05-01 |
2012-11-08 |
University Of Rochester |
Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
|
|
EP2705370A2
(en)
|
2011-05-06 |
2014-03-12 |
Xentech |
Markers for cancer prognosis and therapy and methods of use
|
|
CA2835641C
(en)
|
2011-05-11 |
2019-05-28 |
Exosome Diagnostics, Inc. |
Nucleic acid extraction from heterogeneous biological materials
|
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
|
CA2835428A1
(en)
*
|
2011-05-17 |
2012-11-22 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof for non-human vertebrates
|
|
PL3892295T3
(pl)
|
2011-05-24 |
2023-07-24 |
BioNTech SE |
Zindywidualizowane szczepionki przeciwnowotworowe
|
|
ES2795110T3
(es)
|
2011-06-08 |
2020-11-20 |
Translate Bio Inc |
Lípidos escindibles
|
|
DK2732052T3
(en)
|
2011-07-15 |
2017-02-20 |
Leo Pharma As |
Diagnostic microRNA profiling in cutaneous T cell lymphoma (CTCL)
|
|
EP2751292A4
(en)
|
2011-09-01 |
2015-05-20 |
Allegro Diagnostics Corp |
METHOD AND COMPOSITIONS FOR DETECTING CANCER BASED ON MIRNA EXPRESSION PROFILES
|
|
WO2013036201A1
(en)
|
2011-09-06 |
2013-03-14 |
Agency For Science, Technology And Research |
Polypeptide vaccine
|
|
US20140243240A1
(en)
|
2011-10-26 |
2014-08-28 |
Georgetown University |
microRNA EXPRESSION PROFILING OF THYROID CANCER
|
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
|
WO2013086354A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
CA3018046A1
(en)
*
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
WO2013103659A1
(en)
|
2012-01-04 |
2013-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
|
|
WO2013116126A1
(en)
|
2012-02-01 |
2013-08-08 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
|
|
WO2013120500A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
|
|
CN103547683A
(zh)
*
|
2012-03-22 |
2014-01-29 |
耶鲁大学 |
Kras突变和肿瘤生物学
|
|
CN104411338A
(zh)
|
2012-04-02 |
2015-03-11 |
现代治疗公司 |
用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
KR20150004416A
(ko)
|
2012-04-30 |
2015-01-12 |
글렌 엔. 바버 |
면역 반응의 조절
|
|
ES3039913T3
(en)
*
|
2012-05-09 |
2025-10-27 |
Gradalis Inc |
Bi-functional short-hairpin rna (bi-shrna) specific for single-nucleotide kras mutations
|
|
EP2858722B8
(en)
|
2012-06-08 |
2018-02-21 |
Aduro BioTech, Inc. |
Compostions and methods for cancer immunotherapy
|
|
CA2878314A1
(en)
*
|
2012-07-16 |
2014-01-23 |
Kyowa Hakko Kirin Co., Ltd. |
Rnai pharmaceutical composition for suppressing expression of kras gene
|
|
WO2014037124A1
(en)
|
2012-09-04 |
2014-03-13 |
Bavarian Nordic A/S |
Methods and compositions for enhancing vaccine immune responses
|
|
EP2892930B1
(en)
|
2012-09-07 |
2019-08-14 |
University Of Miami |
Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
|
|
WO2014093924A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
EP3417874B1
(en)
|
2012-11-28 |
2024-09-11 |
BioNTech SE |
Individualized vaccines for cancer
|
|
AU2013374345A1
(en)
|
2013-01-17 |
2015-08-06 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
ES2662333T3
(es)
|
2013-02-14 |
2018-04-06 |
Immunocellular Therapeutics Ltd. |
Vacunas contra el cáncer y métodos de vacunación
|
|
US20160022840A1
(en)
|
2013-03-09 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Heterologous untranslated regions for mrna
|
|
EP2968391A1
(en)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
KR20150130283A
(ko)
|
2013-03-15 |
2015-11-23 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
생체분자 보조제를 갖는 백신
|
|
WO2014166501A2
(en)
|
2013-04-10 |
2014-10-16 |
Skau Aps |
Use of immune suppressive peptides as adjuvants
|
|
US9840533B2
(en)
|
2013-04-29 |
2017-12-12 |
Memorial Sloan Kettering Cancer Center |
Compositions and methods for altering second messenger signaling
|
|
WO2014179760A1
(en)
|
2013-05-03 |
2014-11-06 |
The Regents Of The University Of California |
Cyclic di-nucleotide induction of type i interferon
|
|
WO2014189806A1
(en)
|
2013-05-18 |
2014-11-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
PE20160080A1
(es)
|
2013-05-18 |
2016-02-21 |
Aduro Biotech Inc |
Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon
|
|
US10176292B2
(en)
|
2013-07-31 |
2019-01-08 |
Memorial Sloan-Kettering Cancer Center |
STING crystals and modulators
|
|
CA2927009C
(en)
|
2013-10-21 |
2019-04-23 |
Drexel University |
Use of sting agonists to treat chronic hepatitis b virus infection
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
JP2016538344A
(ja)
|
2013-11-19 |
2016-12-08 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
癌処置としてのｓｔｉｎｇアゴニストの使用
|
|
JP6781403B2
(ja)
|
2013-12-09 |
2020-11-04 |
タルゴバックス エーエスエー |
ペプチド混合物
|
|
US10421971B2
(en)
|
2014-01-15 |
2019-09-24 |
The University Of Chicago |
Anti-tumor therapy
|
|
WO2015123532A1
(en)
*
|
2014-02-16 |
2015-08-20 |
Globeimmune, Inc. |
Ras g12r immunotherapy for ras mutation-positive cancers
|
|
US10821175B2
(en)
|
2014-02-25 |
2020-11-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
CA2942501A1
(en)
|
2014-03-17 |
2015-09-24 |
Tapimmune Inc. |
Nucleic acid molecule vaccine compositions and uses thereof
|
|
PL4023249T3
(pl)
*
|
2014-04-23 |
2025-03-10 |
Modernatx, Inc. |
Szczepionki z kwasem nukleinowym
|
|
EP3134546A4
(en)
*
|
2014-04-24 |
2017-12-06 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
|
US9757439B2
(en)
*
|
2014-05-06 |
2017-09-12 |
Targovax Asa |
Peptide vaccine comprising mutant RAS peptide and chemotherapeutic agent
|
|
HUE060907T2
(hu)
|
2014-06-25 |
2023-04-28 |
Acuitas Therapeutics Inc |
Új lipidek és lipid nanorészecske formulációk nukleinsavak bevitelére
|
|
JP2017530114A
(ja)
|
2014-09-26 |
2017-10-12 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
フラジェリンをコードする組み換えｍｖａによる鼻腔内免疫のための方法と組成物
|
|
MA40737A
(fr)
|
2014-11-21 |
2017-07-04 |
Memorial Sloan Kettering Cancer Center |
Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1
|
|
JP2018516847A
(ja)
|
2015-03-25 |
2018-06-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
生体高分子薬を送達するための組成物及び方法
|
|
CN108064176A
(zh)
|
2015-04-22 |
2018-05-22 |
库瑞瓦格股份公司 |
用于治疗肿瘤疾病的含有rna的组合物
|
|
AU2016253972B2
(en)
|
2015-04-27 |
2020-01-02 |
Acuitas Therapeutics Inc. |
Nucleoside-modified RNA for inducing an adaptive immune response
|
|
IL294183B2
(en)
|
2015-05-20 |
2023-10-01 |
Dana Farber Cancer Inst Inc |
shared neoantigens
|
|
WO2016201450A2
(en)
|
2015-06-11 |
2016-12-15 |
University Of Miami |
Cancer treatment and diagnosis
|
|
BR112017025728A2
(pt)
*
|
2015-06-16 |
2018-08-07 |
Targovax Asa |
fragmentos mutantes da proteína ras
|
|
US20180296663A1
(en)
|
2015-06-17 |
2018-10-18 |
Curevac Ag |
Vaccine composition
|
|
MA42502A
(fr)
*
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
MA42543A
(fr)
*
|
2015-07-30 |
2018-06-06 |
Modernatx Inc |
Arn épitope peptidiques concatémériques
|
|
CA2993429A1
(en)
|
2015-07-31 |
2017-02-09 |
Tarveda Therapeutics, Inc. |
Compositions and methods for immuno-oncology therapies
|
|
JP6948313B6
(ja)
*
|
2015-09-17 |
2022-01-14 |
モデルナティエックス インコーポレイテッド |
治療剤の細胞内送達のための化合物および組成物
|
|
US10322177B2
(en)
|
2015-10-07 |
2019-06-18 |
Nant Holdings Ip, Llc |
Activation of immune-related signaling pathways in cells via optofection
|
|
MX2018004544A
(es)
|
2015-10-12 |
2018-11-09 |
Nantomics Llc |
Composiciones y métodos para los neoepítopos de cáncer viral.
|
|
BR112018007870A2
(pt)
|
2015-10-19 |
2019-01-15 |
Cadila Healthcare Ltd |
composição imunogênica, método para a preparação de uma composição imunogênica, composição farmacêutica, vacina, método para estimular uma resposta imune em um paciente
|
|
AU2016341309A1
(en)
*
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Cancer vaccines
|
|
HRP20230209T1
(hr)
|
2015-10-28 |
2023-04-14 |
Acuitas Therapeutics Inc. |
Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
|
|
WO2017112830A1
(en)
|
2015-12-21 |
2017-06-29 |
La Jolla Institute For Allergy And Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
EP3400005A1
(en)
|
2016-01-08 |
2018-11-14 |
Vaccibody AS |
Neoepitope rna cancer vaccine
|
|
WO2017152042A2
(en)
|
2016-03-04 |
2017-09-08 |
New York University |
Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity
|
|
WO2017177204A1
(en)
|
2016-04-09 |
2017-10-12 |
La Jolla Institute For Allergy And Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
CN109328070A
(zh)
|
2016-05-04 |
2019-02-12 |
免疫疫苗技术有限公司 |
包含两亲化合物、新抗原和疏水载体的疫苗组合物及其使用方法
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
CN109890408A
(zh)
|
2016-05-27 |
2019-06-14 |
埃特彼塞斯公司 |
新表位疫苗组合物及其使用方法
|
|
US12257352B2
(en)
|
2016-06-20 |
2025-03-25 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of biomacromolecule agents
|
|
SG11201900132QA
(en)
|
2016-07-20 |
2019-02-27 |
Biontech Rna Pharmaceuticals Gmbh |
Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy
|
|
EP3503876A4
(en)
|
2016-08-23 |
2020-06-10 |
Jerome J. Schentag |
CHOLESTERYL ESTER VESICLES LOADING PEPTIDES, PROTEINS AND NUCLEIC ACIDS IN CHYLOMICRONS AND BODY CELLS
|
|
CN110402145A
(zh)
*
|
2016-10-26 |
2019-11-01 |
莫得纳特斯公司 |
用于增强免疫应答的信使核糖核酸及其使用方法
|
|
US20200206334A1
(en)
|
2016-11-04 |
2020-07-02 |
Hookipa Biotech Gmbh |
Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines
|
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
CA3035591A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
|
|
KR20190112263A
(ko)
|
2016-12-12 |
2019-10-04 |
멀티비르 인코포레이티드 |
암 및 감염성 질환의 치료 및 예방을 위한 바이러스 유전자 치료요법 및 면역 체크포인트 억제제를 포함하는 방법 및 조성물
|
|
BR112019015797A2
(pt)
|
2017-02-01 |
2020-03-17 |
Modernatx, Inc. |
Composições de mrna terapêuticas imunomoduladoras que codificam peptídeos de mutação de oncogene de ativação
|